Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukimichi Imai

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Reality orientation training]Masami Hasebe, Yukimichi Imai
Dementia and Geriatric Cognitive Disorders|February 14, 2008
Validation of the 7-Minute Screen for the detection of early-stage Alzheimer's diseaseMutsuo Ijuin, Akira Homma, Masaru Mimura, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's diseaseYu Nakamura, Yukimichi Imai, Masahiro Shigeta, et al.
Dementia and Geriatric Cognitive Disorders Extra|August 4, 2012
CIBIC Plus-J Assessment Using a Videotaped Method in Alzheimer's Disease PatientsYu Nakamura, Mikiko Usui, Takashi Nishikawa, et al.
Dementia and Geriatric Cognitive Disorders|April 9, 2008
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trialAkira Homma, Yukimichi Imai, Hisao Tago, et al.
Dementia and Geriatric Cognitive Disorders|February 28, 2009
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in JapanAkira Homma, Yukimichi Imai, Hisao Tago, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2012
[Reality orientation training]Masami Hasebe, Yukimichi Imai
Dementia and Geriatric Cognitive Disorders|February 14, 2008
Validation of the 7-Minute Screen for the detection of early-stage Alzheimer's diseaseMutsuo Ijuin, Akira Homma, Masaru Mimura, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's diseaseYu Nakamura, Yukimichi Imai, Masahiro Shigeta, et al.
Dementia and Geriatric Cognitive Disorders Extra|August 4, 2012
CIBIC Plus-J Assessment Using a Videotaped Method in Alzheimer's Disease PatientsYu Nakamura, Mikiko Usui, Takashi Nishikawa, et al.
Dementia and Geriatric Cognitive Disorders|April 9, 2008
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trialAkira Homma, Yukimichi Imai, Hisao Tago, et al.
Dementia and Geriatric Cognitive Disorders|February 28, 2009
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in JapanAkira Homma, Yukimichi Imai, Hisao Tago, et al.
Pageof 1